Is the starting price the maintenance cost?
Not necessarily. Confirm dose, supply period, eligibility and ongoing price; manufacturer offers can change.
As of October 8, 2026, Ozempic without insurance costs $349 a month for the 0.25, 0.5 or 1 mg pen and $499 for the 2 mg pen on Novo Nordisk’s self-pay offer (Ozempic savings page); eligible new patients pay $199 for their first two fills. The list price is $1,027.51 per pen (NovoCare).
Quick answer: $349 a month for the 0.25, 0.5 or 1 mg pen and $499 for the 2 mg pen on Novo Nordisk’s self-pay offer, as of October 8, 2026.
As checked October 8, 2026, Novo Nordisk advertises $199 for each of the first two monthly fills of the 0.25 or 0.5 mg starting doses for eligible new patients, with fills through December 31, 2026. Ongoing prices are $349 for 0.25, 0.5 or 1 mg and $499 for 2 mg. The manufacturer defines a month as one box containing one pen. Eligibility and changeable terms apply; this is not a price promise for every prescription. Source: Ozempic manufacturer savings terms
| Ozempic without insurance | Price | Conditions | Source |
|---|---|---|---|
| Pen 0.25 or 0.5 mg, first two fills | $199 | New patients only; per pen (one month); redeemed and filled by December 31, 2026 | Ozempic savings page |
| Pen 0.25, 0.5 or 1 mg | $349 | Per pen (one month), self-pay | Ozempic savings page |
| Pen 2 mg | $499 | Per pen (one month), self-pay | Ozempic savings page |
| Tablets 1.5 mg / 4 mg / 9 mg | $149 / $199 / $299 | Per bottle of 30 tablets, self-pay | NovoCare offer terms |
| Costco member price, pen 1 mg | $349 | Costco members; cash outside insurance | Costco price search |
| GoodRx coupon, as low as | $149 | The 1.5 mg tablet; GoodRx does not show a pharmacy or location | GoodRx |
| List price | $1,027.51 | Per pen, before discounts and rebates; not what most people pay | NovoCare |
All figures checked October 8, 2026. The intro price applies only to new patients and only to the two starting doses, so budget on the ongoing price.
Quick answer: Yes. With commercial coverage for Ozempic, Novo’s savings offer can bring a fill to as little as $25; government plans cannot use that offer.
Coverage depends on the drug, diagnosis, plan formulary and prior authorization. Ask about the cost after your deductible and any required clinical documentation. Commercial savings and self-pay offers have different rules: the $25 offer is capped per fill and excludes people with Medicare, Medicaid or other government coverage (NovoCare offer terms). Medicare GLP-1 Bridge is a temporary program for certain eligible beneficiaries beginning in July 2026; it does not mean automatic coverage for everyone. CMS: Medicare GLP-1 Bridge eligibility
Quick answer: REMEVi bills every four weeks, not by calendar month, and the 3-month and 6-month plans are paid upfront. These are compounded preparations, not Ozempic.
REMEVi prices are per month, billed in four-week periods that are not calendar months. The 3-month and 6-month plans require the full total upfront. Lab work that the clinician requires for treatment is included.
| Compounded preparation | Monthly | 3-month plan: total upfront | 6-month plan: total upfront |
|---|---|---|---|
| Injectable semaglutide | $199 | $507 ($169 / month) | $954 ($159 / month) |
| Injectable tirzepatide | $269 | $699 ($233 / month) | $1,350 ($225 / month) |
| Compounded oral semaglutide | $249 | $687 ($229 / month) | $1,290 ($215 / month) |
See current semaglutide and tirzepatide plan details. Compounded oral semaglutide is not an approved Wegovy, Ozempic or Rybelsus tablet. Eligibility and prescribing depend on clinical evaluation. Service is available in 49 states and Washington, DC, excluding Louisiana.
Quick answer: No. Compounded preparations are not FDA-approved, are not generics of Ozempic or any brand, and have no established clinical equivalence to them.
Compounded preparations are not FDA-approved, are not generics of the brands and do not have established clinical equivalence to them. FDA recommends their use only when an available approved product cannot meet the medical need. A lower price does not establish equal safety or effectiveness. Source: FDA: unapproved GLP-1 medicines
Quick answer: The product, route, pharmacy, supply length, full upfront payment, refill terms and cancellation policy — and who handles side effects.
Confirm the product, route, pharmacy, supply length, full upfront payment, refill terms and cancellation policy. Ask who handles side effects and what happens if clinical review does not recommend treatment. Review care options.
Not necessarily. Confirm dose, supply period, eligibility and ongoing price; manufacturer offers can change.
No. Prices are per month, billed every four weeks. The 3-month and 6-month plans require the full total upfront; clinician-required labs are included.
As of October 8, 2026, Novo Nordisk's self-pay price is $349 a month for the 0.25, 0.5 or 1 mg pen and $499 for 2 mg. Eligible new patients pay $199 for each of the first two fills of 0.25 or 0.5 mg, through December 31, 2026.
On October 8, 2026, Costco's member price search showed $199 for the 0.25/0.5 mg pen (limited to 2 fills), $349 for 1 mg and $499 for 2 mg. It is a member price for cash buyers outside insurance.
No. The $25 savings offer requires commercial insurance that covers Ozempic, and people with Medicare, Medicaid or other government coverage cannot use it. Without insurance, the self-pay price applies.
Free 1-minute quiz, then a 2-minute intake if you qualify. A licensed clinician reviews your information. If prescribed, medication is delivered to your door.
See if you qualifyFree · about 1 minute · no card required